Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Ticker SymbolRGC
CompanyRegencell Bioscience Holdings Ltd
CEO
Websitehttps://www.regencellbioscience.com/
FAQs
What is the current price of Regencell Bioscience Holdings Ltd (RGC)?
The current price of Regencell Bioscience Holdings Ltd (RGC) is 45.790.
What is the symbol of Regencell Bioscience Holdings Ltd?
The ticker symbol of Regencell Bioscience Holdings Ltd is RGC.
What is the 52-week high of Regencell Bioscience Holdings Ltd?
The 52-week high of Regencell Bioscience Holdings Ltd is 83.600.
What is the 52-week low of Regencell Bioscience Holdings Ltd?
The 52-week low of Regencell Bioscience Holdings Ltd is 0.093.
What is the market capitalization of Regencell Bioscience Holdings Ltd?
The market capitalization of Regencell Bioscience Holdings Ltd is 22.64B.
What is the net income of Regencell Bioscience Holdings Ltd?
The net income of Regencell Bioscience Holdings Ltd is -3.58M.
Is Regencell Bioscience Holdings Ltd (RGC) currently rated as Buy, Hold, or Sell?
According to analysts, Regencell Bioscience Holdings Ltd (RGC) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Regencell Bioscience Holdings Ltd (RGC)?
The Earnings Per Share (EPS TTM) of Regencell Bioscience Holdings Ltd (RGC) is -0.008.